ÂÜÀòÂÒÂ×

Michael A. Grosso MD, FACS currently serves as the Vice President and Global Head of Clinical Development for Specialty Medicine at Daiichi Sankyo, Inc., a position held since December 2010, having previously advanced through roles including Executive Director of Cardiovascular Clinical Development. Additionally, Michael A. Grosso is an Advisory Board Member at Perosphere Technologies. Prior experience includes serving as Director of Medical Advisor for Cardio/Thrombosis at sanofi-aventis and holding academic and clinical roles at the University of Pennsylvania and UMDNJ/Cooper University. Michael A. Grosso earned an MD from the University of Pennsylvania School of Medicine and a BS in Biology from the University of the Sciences in Philadelphia.